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Foreword
When the 2005-2006 Executive Board first approached the
formidable task of selecting articles for publication in the Winter
edition of Volume 15 of the Annals of Health Law, we planned
to select articles related to a single theme in health law. How-
ever, we soon realized that to focus on one narrow subject
would ignore the opportunity to explore the numerous develop-
ing areas in health law. Thus, we settled on five very different
topics, represented by five scholarly and timely articles. Each
piece not only discusses an ongoing debate in health law, but
also reflects the twists these debates are beginning to take.
Similar to the abortion debate that started decades ago, stem
cell research has sparked a religious, legal, and moral contro-
versy. Rooted in such difficult-to-answer questions as whether
life begins at conception and whether moral beliefs should cur-
tail research advancement, stem cell research has generated a
social and political outcry. In her article, "The States 'Race'
with the Federal Government for Stem Cell Research," Joanna
Sax explores the political reaction to this debate. Specifically,
Dr. Sax proposes how, despite a federal ban on creating new
stem cell lines, individual states and private institutes may push
stem cell research forward. She describes states as "laborato-
ries" for federal policy that experiment with different ap-
proaches to stem cell research and analyzes the potential impact
of such state legislation.
Like stem cell research, contraceptive use also raises moral,
ethical and religious concerns. In fact, some of the same ques-
tions debated in relation to stem cell research, such as when life
begins, arise with contraceptive use. Mary Collins looks at the
conflict between access to useful medication and moral beliefs in
her article, "Conscience Clauses and Oral Contraceptives: Con-
scientious Objection or Calculated Obstruction?" Ms. Collins
explores recent state legislation, called conscience clauses, al-
lowing health care providers to refuse to dispense certain con-
traceptives because of personal beliefs.
The next article, "Is Obesity Really the Next Tobacco? Les-
sons Learned from Tobacco for Obesity Litigation," is authored
by Brooke Courtney. We selected Ms. Courtney's article from
the top twenty percent of articles submitted to the Seventh An-
nual Epstein Becker & Green Health Law Writing Competition.
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Ms. Courtney combines two areas of the law that have indepen-
dently received much attention: obesity litigation and tobacco
litigation. In a unique approach to these issues, Ms. Courtney
explores obesity litigation as the "next tobacco" and discusses
what lessons from tobacco litigation can be used for obesity
litigation.
Much like their counterparts in the tobacco and fast-food in-
dustries, pharmaceutical companies have also been the focus of
recently increased scrutiny, in particular because of the high cost
of prescription drugs. Faced with criticism from the federal gov-
ernment, state governments, and the plaintiff's bar, the pharma-
ceutical industry finds itself in an environment of confusion and
uncertainty. Authors Jonathan K. Henderson and Quintin Cas-
sady provide clarity by explaining recent governmental enforce-
ment actions and the implementation of successful compliance
programs in their article, "Drug Deals in 2006: Cutting Edge Le-
gal and Regulatory Issues in the Pharmaceutical Industry."
Finally, William Gunnar, a cardiac surgeon, draws from per-
sonal experience in his article, "The Fundamental Law that
Shapes the United States Health Care System: Is Universal
Health Care Realistic Within the Established Paradigm?" Dr.
Gunnar describes the uninsured patient population and exam-
ines the current social contract between health care providers
and uninsured patients. Dr. Gunnar also analyzes federal stat-
utes that define who may receive federal and state health care
funding and concludes that these statutes, in conjunction with
constitutional jurisprudence, prevent universal health care from
ever being achieved in the U.S.
In conclusion, we hope you enjoy the unique perspectives on
several recurring debates in health law that these articles pro-
vide. The staff certainly enjoyed working with these authors in
publishing their contributions to this issue of the Annals of
Health Law and would like to thank them for their assistance
along the way. We look forward to your input and wish you the
best in the New Year!
Ann Meckstroth
Editor-in-Chief
J.D. Candidate, May 2006
John Blum
Faculty Advisor
John J. Waldron Research Professor in Health Law
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